These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 15819386)

  • 1. Interaction of arylpiperazines with the dopamine receptor D2 binding site.
    Sukalović V; Zlatović M; Andrić D; Roglić G; Kostić-Rajacić S; Soskić V
    Arzneimittelforschung; 2005; 55(3):145-52. PubMed ID: 15819386
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modeling of the D2 dopamine receptor arylpiperazine binding site for 1-[2-[5-(1H-benzimidazole-2-thione)]ethyl]-4-arylpiperazines.
    Sukalović V; Zlatović M; Andrić D; Roglić G; Kostić-Rajaccić S; Soskić V
    Arch Pharm (Weinheim); 2004 Sep; 337(9):502-12. PubMed ID: 15362123
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis, dopamine D2 receptor binding studies and docking analysis of 5-[3-(4-arylpiperazin-1-yl)propyl]-1H-benzimidazole, 5-[2-(4-arylpiperazin-1-yl)ethoxy]-1H-benzimidazole and their analogs.
    Sukalović V; Andrić D; Roglić G; Kostić-Rajacić S; Schrattenholz A; Soskić V
    Eur J Med Chem; 2005 May; 40(5):481-93. PubMed ID: 15893022
    [TBL] [Abstract][Full Text] [Related]  

  • 4. N4-unsubstituted N1-arylpiperazines as high-affinity 5-HT1A receptor ligands.
    Kuipers W; van Wijngaarden I; Kruse CG; ter Horst-van Amstel M; Tulp MT; IJzerman AP
    J Med Chem; 1995 May; 38(11):1942-54. PubMed ID: 7783126
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis, Biological, and Computational Evaluation of Substituted 1-(2-Methoxyphenyl)-4-(1-phenethylpiperidin-4-yl)piperazines and 1-(2-Methoxyphenyl)-4-[(1-phenethylpiperidin-4-yl)methyl]piperazines as Dopaminergic Ligands.
    Penjišević JZ; Šukalović VV; Andrić DB; Roglić GM; Šoškić V; Kostić-Rajačić SV
    Arch Pharm (Weinheim); 2016 Aug; 349(8):614-26. PubMed ID: 27335270
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure-affinity relationship studies on D-2/5-HT1A receptor ligands. 4-(2-Heteroarylethyl)-1-arylpiperazines.
    Dukić S; Vujović M; Soskić V; Joksimović J
    Arzneimittelforschung; 1997 Mar; 47(3):239-43. PubMed ID: 9105540
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exploration of N-arylpiperazine Binding Sites of D2 Dopaminergic Receptor.
    Soskic V; Sukalovic V; Kostic-Rajacic S
    Mini Rev Med Chem; 2015; 15(12):988-1001. PubMed ID: 25723457
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 1-cinnamyl-4-(2-methoxyphenyl)piperazines: synthesis, binding properties, and docking to dopamine (D(2)) and serotonin (5-HT(1A)) receptors.
    Penjisević J; Sukalović V; Andrić D; Kostić-Rajacić S; Soskić V; Roglić G
    Arch Pharm (Weinheim); 2007 Sep; 340(9):456-65. PubMed ID: 17763374
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and structure-activity relationships of a new model of arylpiperazines. 5. Study of the physicochemical influence of the pharmacophore on 5-HT(1a)/alpha(1)-adrenergic receptor affinity: synthesis of a new derivative with mixed 5-HT(1a)/d(2) antagonist properties.
    López-Rodríguez ML; Morcillo MJ; Fernández E; Porras E; Orensanz L; Beneytez ME; Manzanares J; Fuentes JA
    J Med Chem; 2001 Jan; 44(2):186-97. PubMed ID: 11170628
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular modeling of the dopamine D2 and serotonin 5-HT1A receptor binding modes of the enantiomers of 5-OMe-BPAT.
    Homan EJ; Wikström HV; Grol CJ
    Bioorg Med Chem; 1999 Sep; 7(9):1805-20. PubMed ID: 10530928
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The dopamine D2 receptor dimer and its interaction with homobivalent antagonists: homology modeling, docking and molecular dynamics.
    Kaczor AA; Jörg M; Capuano B
    J Mol Model; 2016 Sep; 22(9):203. PubMed ID: 27491852
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New arylpiperazine derivatives with high affinity for alpha1A, D2 and 5-HT2A receptors.
    González-Gómez JC; Santana L; Uriarte E; Brea J; Villazón M; Loza MI; De Luca M; Rivas ME; Montenegro GY; Fontenla JA
    Bioorg Med Chem Lett; 2003 Jan; 13(2):175-8. PubMed ID: 12482418
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mixed dopaminergic/serotonergic properties of several 2-substituted 4-[2-(5-benzimidazole)ethyl]-1-arylpiperazines.
    Kostic-Rajacic S; Soskic V; Joksimovic J
    Arch Pharm (Weinheim); 1998 Jan; 331(1):22-6. PubMed ID: 9507698
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Electrostatic surface potential calculation on several new halogenated benzimidazole-like dopaminergic ligands.
    Sukalović V; Andrić D; Roglić G; Kostić-Rajaccić S; Soskić V
    Arch Pharm (Weinheim); 2004 Jul; 337(7):376-82. PubMed ID: 15237387
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 5-HT1A-versus D2-receptor selectivity of flesinoxan and analogous N4-substituted N1-arylpiperazines.
    Kuipers W; Kruse CG; van Wijngaarden I; Standaar PJ; Tulp MT; Veldman N; Spek AL; IJzerman AP
    J Med Chem; 1997 Jan; 40(3):300-12. PubMed ID: 9022796
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and structure-activity relationships of new arylpiperazines: para substitution with electron-withdrawing groups decrease binding to 5-HT(1A) and D(2A) receptors.
    Santana L; Uriarte E; Fall Y; Teijeira M; Terán C; García-Martínez E; Tolf BR
    Eur J Med Chem; 2002 Jun; 37(6):503-10. PubMed ID: 12204476
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Certain 1,4-disubstituted aromatic piperidines and piperazines with extreme selectivity for the dopamine D4 receptor interact with a common receptor microdomain.
    Kortagere S; Gmeiner P; Weinstein H; Schetz JA
    Mol Pharmacol; 2004 Dec; 66(6):1491-9. PubMed ID: 15448188
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced D1 affinity in a series of piperazine ring substituted 1-piperazino-3-arylindans with potential atypical antipsychotic activity.
    Bøgesø KP; Arnt J; Frederiksen K; Hansen HO; Hyttel J; Pedersen H
    J Med Chem; 1995 Oct; 38(22):4380-92. PubMed ID: 7473566
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Effect of Carboxamide/Sulfonamide Replacement in Arylpiperazinylalkyl Derivatives on Activity to Serotonin and Dopamine Receptors.
    Kowalski P; Śliwa P; Satała G; Kurczab R; Bartos I; Zuchowicz K
    Arch Pharm (Weinheim); 2017 Oct; 350(10):. PubMed ID: 28846141
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis of several substituted phenylpiperazines behaving as mixed D2/5HT1A ligands.
    Dukić S; Kostić-Rajacić S; Dragović D; Soskić V; Joksimović J
    J Pharm Pharmacol; 1997 Oct; 49(10):1036-41. PubMed ID: 9364416
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.